Syros Pharmaceuticals (SYRS)

$4.72 0.39 (7.63%)

16:00 EDT SYRS Stock Quote Delayed 30 Minutes

SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings Mar 27, 2024

SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential

GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week

Volume:

Previous Close -

Market Cap 97.21M

PE Ratio -5.55

EPS -0.85

Volume (Avg. Vol.) 119,453

Day's Range $4.72 - $5.06

52-Week Range $2.09 - $8.17

Dividend & Yield N/A (N/A)

SYRS Stock Predictions, Articles, and Syros Pharmaceuticals News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 20, 2022

Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 16, 2022

We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 13, 2022

Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Feb 3, 2022

Good morning, trader! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Dec 3, 2021

Good morning, investor! We're at the end of the week and it starts off with the biggest pre-market stock movers for Friday!

7 Best Penny Stocks to Buy for Your June Buy List

By Josh Enomoto, InvestorPlace Contributor Jun 4, 2021

Penny stocks are incredibly volatile financial vehicles not for the faint of heart. That said, you might win big with these offerings.

Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today

By William White, InvestorPlace Writer Dec 18, 2019

Syros Pharmaceuticals (SYRS) news for Wednesday about plans for developing new drugs and a $20 million payment have SYRS stock flying high.

2 Stable and 2 Speculative Biotech Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Jun 15, 2018

Biotech stocks are incredibly wild affairs, but if you have an iron stomach, these four companies could potentially offer serious upside.

Syros Pharmaceuticals director buys stock worth $4M (NASDAQ:SYRS)

From Seeking Alpha Dec 27, 2023

Syros Pharmaceuticals director buys $4M worth of shares, increasing total holding to 1.79M. Stock price up 2.6% in pre-market trading.

Syros Pharmaceuticals director buys sock worth $4M (NASDAQ:SYRS)

From Seeking Alpha Dec 27, 2023

Syros Pharmaceuticals director buys $4M worth of shares, increasing total holding to 1.79M. Stock price up 2.6% in pre-market trading.

Syros prices capital raise of $45.0 million via securities offering (NASDAQ:SYRS)

From Seeking Alpha Dec 19, 2023

Syros (SYRS) has priced an underwritten offering of 4.94 million shares of common stock at an offering price of $4.42 per share, and pre-funded warrants to purchase 5.24 million shares of..

Syros stock jumps after data for leukemia drug (NASDAQ:SYRS)

From Seeking Alpha Dec 6, 2023

Syros Pharmaceuticals (SYRS) stock soars 41% after positive early data from a Phase 2 trial for its oral leukemia drug tamibarotene in combination therapy. Read more here.

Syros Pharmaceuticals announces job cuts, CEO change (NASDAQ:SYRS)

From Seeking Alpha Oct 2, 2023

Syros Pharmaceuticals (SYRS) is cutting its workforce by 35%, appointing a new CEO, and seeing the departure of its chief scientific officer.

Analysts Are Bullish on Top Healthcare Stocks: Kura Oncology (KURA), Syros Pharmaceuticals (SYRS)

From TipRanks Dec 12, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kura Oncology (KURA – Research Report) and Syros Pha...

Syros Pharmaceuticals (SYRS)

SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023

3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential

GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Syros Pharmaceuticals (SYRS)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

SYRS Stock Predictions, Articles, and Syros Pharmaceuticals News

Subscriber Sign in